Literature DB >> 17383430

Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.

Roberta Pang1, Terence K W Lee, Ronnie T P Poon, Sheung T Fan, Kam B Wong, Yok-Lam Kwong, Eric Tse.   

Abstract

BACKGROUND AND AIMS: The peptidyl prolyl isomerase Pin1 frequently is overexpressed in hepatocellular carcinoma (HCC). Hepatitis B virus (HBV) is the most common etiologic agent in HCC, and its encoded X-protein (HBx) is oncogenic and possesses a serine-proline motif that may bind Pin1. The role of Pin1 in hepatocarcinogenesis, particularly in HBV-related HCC, was investigated.
METHODS: Immunohistochemical staining was performed to evaluate the prevalence of Pin1 overexpression in HCCs of different etiologies. Glutathione S-transferase pull-down and co-immunoprecipitation experiments were used to validate the physical interaction between Pin1 and HBx. Reporter assay, cell proliferation assay, and xenotransplantation experiments were used to show the functional consequence and importance of Pin1-HBx interaction in hepatocarcinogenesis.
RESULTS: We showed preferential Pin1 overexpression in HBV-related tumors and confirmed the interaction between Pin1 and HBx at the specific serine-proline motif. Pin1 overexpression increased the protein stability of HBx. Furthermore, HBx-mediated transactivation was enhanced by co-expression of Pin1. HepG2 expressing Pin1 and HBx showed a synergistic increase in cellular proliferation, as compared with cells expressing Pin1 or HBx alone. Furthermore, concomitant expression of Pin1 and HBx in the nontumorigenic human hepatocyte cell line MIHA led to a synergistic increase in tumor growth. Finally, in Hep3B cells with suppressed Pin1 expression, HBx-enhanced tumor growth in nude mice was abrogated.
CONCLUSIONS: Pin1 binds HBx to enhance hepatocarcinogenesis in HBV-infected hepatocytes. The discovery of an interaction between Pin1 and HBx will further our understanding of the molecular pathogenic mechanism of HBV-related HCC in human beings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17383430     DOI: 10.1053/j.gastro.2006.12.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

1.  Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.

Authors:  Min Zheng; Huijuan Xu; Xin-Hua Liao; Champ Peng Chen; Arina Li Zhang; Wenxian Lu; Long Wang; Dayun Yang; Jichuang Wang; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Oncotarget       Date:  2017-05-02

2.  Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.

Authors:  Umar Saeed; Jumi Kim; Zahra Zahid Piracha; Hyeonjoong Kwon; Jaesung Jung; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 3.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Authors:  Kwang Youl Lee; Jeong Woon Lee; Hyun Jeong Nam; Jeong-Hyun Shim; Youngsup Song; Keon Wook Kang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

5.  Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

Authors:  Yohei Narita; Takayuki Murata; Akihide Ryo; Daisuke Kawashima; Atsuko Sugimoto; Teru Kanda; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 6.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

7.  The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.

Authors:  Chi-Wai Cheng; Ka-Wai Leong; Yiu-Ming Ng; Yok-Lam Kwong; Eric Tse
Journal:  J Biol Chem       Date:  2017-11-08       Impact factor: 5.157

8.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.

Authors:  Jiachun Lu; Zhibin Hu; Sheng Wei; Li-E Wang; Zhensheng Liu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

9.  Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Authors:  Jie Liu; Angela Ahiekpor; Li Li; Xianxing Li; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

10.  High-level expression and large-scale preparation of soluble HBx antigen from Escherichia coli.

Authors:  Dong Liu; Liyun Zou; Wanling Li; Li Wang; Yuzhang Wu
Journal:  Biotechnol Appl Biochem       Date:  2009-09-24       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.